Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011)

References

• ChalasaniN, YounossiZ, LavineJE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–2023. doi:10.1002/hep.2576222488764
   PubMed Web of Science ®Google Scholar
• AnguloP. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221–1231 doi: 10.1056/NEJMra01177511961152
   PubMed Web of Science ®Google Scholar
• ViglinoD, Jullian-DesayesI, MinovesM, et al. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. Eur Respir J. 2017;49(6). doi:10.1183/13993003.01923-2016
   PubMed Web of Science ®Google Scholar
• MinakataY, UedaH, AkamatsuK, et al. High COPD prevalence in patients with liver disease. Intern Med. 2010;49(24):2687–2691. doi:10.2169/internalmedicine.49.394821173543
   PubMed Web of Science ®Google Scholar
• JungDH, ShimJY, LeeHR, MoonBS, ParkBJ, LeeYJ. Relationship between non-alcoholic fatty liver disease and pulmonary function. Intern Med J. 2012;42(5):541–546 doi: 10.1111/j.1445-5994.2011.02644.x22181832
   PubMed Web of Science ®Google Scholar
• PengTC, KaoTW, WuLW, et al. Association between pulmonary function and nonalcoholic fatty liver disease in the NHANES III study. Medicine. 2015;94(21):e907. doi:10.1097/MD.000000000000090726020401
   PubMed Web of Science ®Google Scholar
• QinL, ZhangW, YangZ, et al. Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese. BMC Endocr Disord. 2017;17(1):18. doi:10.1186/s12902-017-0168-428330472
   PubMed Web of Science ®Google Scholar
• ViglinoD, PlazanetA, BaillyS, et al. Impact of non-alcoholic fatty liver disease on long-term cardiovascular events and death in chronic obstructive pulmonary disease. Sci Rep. 2018;8(1):16559. doi:10.1038/s41598-018-34988-230410123
   PubMed Web of Science ®Google Scholar
• KimSH, ShinMJ, ShinYB, KimKU. Sarcopenia associated with chronic obstructive pulmonary disease. J Bone Metab. 2019;26(2):65–74 doi: 10.11005/jbm.2019.26.2.6531223602
   PubMedGoogle Scholar
• KooBK, KimD, JooSK, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123–131. doi:10.1016/j.jhep.2016.08.01927599824
   PubMed Web of Science ®Google Scholar
• LeeYH, KimSU, SongK, et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008–2011). Hepatology. 2016;63(3):776–786. doi:10.1002/hep.2837626638128
   PubMed Web of Science ®Google Scholar
• LeeYH, JungKS, KimSU, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008–2011). J Hepatol. 2015;63(2):486–493. doi:10.1016/j.jhep.2015.02.05125772036
   PubMed Web of Science ®Google Scholar
• ZhaiY, XiaoQ. The common mechanisms of sarcopenia and NAFLD. Biomed Res Int. 2017;2017:6297651. doi:10.1155/2017/629765129387723
   PubMed Web of Science ®Google Scholar
• KweonS, KimY, JangMJ, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43(1):69–77. doi:10.1093/ije/dyt22824585853
   PubMed Web of Science ®Google Scholar
• KimY. The Korea National Health and Nutrition Examination Survey (KNHANES): current status and challenges. Epidemiol Health. 36:e2014002 2014;doi:10.4178/epih/e201400224839580
   PubMedGoogle Scholar
• LeeJH, KimD, KimHJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503–508. doi:10.1016/j.dld.2009.08.00219766548
   PubMedGoogle Scholar
• AnguloP, HuiJM, MarchesiniG, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–854. doi:10.1002/hep.2149617393509
   PubMed Web of Science ®Google Scholar
• GrundySM, CleemanJI, DanielsSR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.16940416157765
   PubMed Web of Science ®Google Scholar
• StudenskiSA, PetersKW, AlleyDE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontology: Series A. 2014;69(5):547–558. doi:10.1093/gerona/glu010
   PubMed Web of Science ®Google Scholar
• LeeYH, KimJE, RohYH, et al. The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008–2011. J Clin Endocrinol Metab. 2014;99(10):3879–3888. doi:10.1210/jc.2013-376424878040
   PubMed Web of Science ®Google Scholar
• ChenLK, LiuLK, WooJ, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:10.1016/j.jamda.2013.11.02524461239
   PubMed Web of Science ®Google Scholar
• MoonSW, KimSY, JungJY, et al. Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007–2010. Int J Chron Obstruct Pulmon Dis. 2018;13:2603–2611. doi:10.2147/COPD.S16690230214178
   PubMed Web of Science ®Google Scholar
• KotronenA, PeltonenM, HakkarainenA, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137(3):865–872. doi:10.1053/j.gastro.2009.06.00519524579
   PubMed Web of Science ®Google Scholar
• SongJU, JangY, LimSY, et al. Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: a longitudinal cohort study. PLoS One. 2019;14(1):e0208736. doi:10.1371/journal.pone.020873630673698
   PubMed Web of Science ®Google Scholar
• ByunMK, ChoEN, ChangJ, AhnCM, KimHJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:669–675. doi:10.2147/COPD.S13079028255238
   PubMed Web of Science ®Google Scholar
• WagnerPD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008;31(3):492–501 doi: 10.1183/09031936.0007480718310396
   PubMed Web of Science ®Google Scholar
• JonesSE, MaddocksM, KonSS, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70(3):213–218. doi:10.1136/thoraxjnl-2014-20644025561517
   PubMed Web of Science ®Google Scholar
• BenzE, TrajanoskaK, LahousseL, et al. Sarcopenia in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2019;28:154. doi:10.1183/16000617.0049-2019
   Web of Science ®Google Scholar
• MaltaisF, DecramerM, CasaburiR, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–62. doi:10.1164/rccm.201402-0373ST24787074
   PubMed Web of Science ®Google Scholar
• HongHC, HwangSY, ChoiHY, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology. 2014;59(5):1772–1778. doi:10.1002/hep.2671623996808
   PubMed Web of Science ®Google Scholar
• WijarnpreechaK, PanjawatananP, ThongprayoonC, JaruvongvanichV, UngprasertP. Sarcopenia and risk of nonalcoholic fatty liver disease: a meta-analysis. Saudi J Gastroenterol. 2018;24(1):12–17 doi: 10.4103/sjg.SJG_237_1729451179
   PubMed Web of Science ®Google Scholar
• KimG, LeeSE, LeeYB, et al. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a 7-year longitudinal study. Hepatology. 2018;68(5):1755–1768. doi:10.1002/hep.3004929679374
   PubMed Web of Science ®Google Scholar
• PacificoL, PerlaFM, ChiesaC. Sarcopenia and nonalcoholic fatty liver disease: a causal relationship. Hepatobiliary Surg Nutr. 2019;8(2):144–147 doi: 10.21037/hbsn.2018.11.1131098363
   PubMed Web of Science ®Google Scholar
• UtzschneiderKM, KahnSE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006;91(12):4753–4761 doi: 10.1210/jc.2006-058716968800
   PubMed Web of Science ®Google Scholar
• SeoJA, ChoH, EunCR, et al. Association between visceral obesity and sarcopenia and vitamin D deficiency in older Koreans: the Ansan Geriatric Study. J Am Geriatr Soc. 2012;60(4):700–706. doi:10.1111/j.1532-5415.2012.03887.x22316299
   PubMed Web of Science ®Google Scholar
• ScottD, BlizzardL, FellJ, DingC, WinzenbergT, JonesG. A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol (Oxf). 2010;73(5):581–587 doi: 10.1111/j.1365-2265.2010.03858.x20681994
   PubMed Web of Science ®Google Scholar
• BarchettaI, AngelicoF, Del BenM, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85. doi:10.1186/1741-7015-9-8521749681
   PubMed Web of Science ®Google Scholar
• BeyerI, MetsT, BautmansI. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care. 2012;15(1):12–22 doi: 10.1097/MCO.0b013e32834dd29722108098
   PubMed Web of Science ®Google Scholar
• SeoYY, ChoYK, BaeJC, et al. Tumor necrosis factor-α as a predictor for the development of nonalcoholic fatty liver disease: a 4-year follow-up study. Endocrinol Metabol. 2013;28(1):41–45. doi:10.3803/EnM.2013.28.1.41
   Google Scholar
• WangK. Molecular mechanisms of hepatic apoptosis. Cell Death Dis. 5:e996 2014;doi:10.1038/cddis.2013.49924434519
   PubMed Web of Science ®Google Scholar
• MaKL, RuanXZ, PowisSH, ChenY, MoorheadJF, VargheseZ. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology. 2008;48(3):770–781 doi: 10.1002/hep.2242318752326
   PubMed Web of Science ®Google Scholar
• HotamisligilGS, ShargillNS, SpiegelmanBM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87–91 doi: 10.1126/science.76781837678183
   PubMed Web of Science ®Google Scholar
• MachadoFVC, PittaF, HernandesNA, BertoliniGL. Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance. Endocrine. 2018;61(1):17–22 doi: 10.1007/s12020-018-1554-z29512058
   PubMed Web of Science ®Google Scholar
• JanssensW, MathieuC, BoonenS, DecramerM. Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle. Vitam Horm. 2011;86:379–399.21419281
   PubMed Web of Science ®Google Scholar
• JolliffeDA, GreenbergL, HooperRL, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019;74(4):337–345. doi:10.1136/thoraxjnl-2018-21209230630893
   PubMed Web of Science ®Google Scholar
• BarnesPJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183–192 doi: 10.1038/nri225418274560
   PubMed Web of Science ®Google Scholar